Advertisement

Bladder Hydrodistension in 2017

  • Claus RiedlEmail author
Chapter
  • 468 Downloads

Abstract

The role of bladder hydrodistension as diagnostic and therapeutic tool in bladder pain syndrome/interstitial cystitis (BPS/IC), as popularized by Messing and Stamey in 1978, has been significantly questioned within the last years. While hydrodistension under anesthesia may give temporary symptom relief in BS/IC, it does not cure the disease. Combination with EMDA, hyaluronic acid or fulguration may improve response rates. No data about effectiveness of repeat treatments exist. However, as with repeated fulgurations or resections, repeated hydrodistension may induce bladder fibrosis and shrinkage and finally lead to cystectomy consequent to minimal bladder capacity.

References

  1. 1.
    National Institute of Diabetes and Digestive and Kidney Diseases: Consensus Meeting on IC/BPS, February 10, 2007. Washington, DC: US Government Printing Office 2007; NIH Publication No. 7-5512.Google Scholar
  2. 2.
    Merwe JPVD, Nordling J, Bouchelouche P, Bouchelouche K, Cervigni M, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008;53:60–7.CrossRefPubMedGoogle Scholar
  3. 3.
    Wennevik GE, Meijlink JM, Hanno P, Nordling J. The role of glomerulations in bladder pain syndrome: a review. J Urol. 2016;195:19–25.CrossRefPubMedGoogle Scholar
  4. 4.
    Bumpus HC. Interstitial cystitis: its treatment by overdistension of the bladder. Med Clin North Am. 1930;13:1495.Google Scholar
  5. 5.
    Sehn JT. The ultrastructural effect of prolonged distension on the neuromuscular apparatus of the bladder. M.Sc. thesis, University of Oxford, 1976.Google Scholar
  6. 6.
    Chai TC, Zhang CO, Shoenfelt JL, Johnson HW, Warren JW, Keays S. Bladder stretch alters urinary heparin-binding epidermal growth factor and antiproliferative factor in patients with interstitial cystitis. J Urol. 2000;163:1440–4.CrossRefPubMedGoogle Scholar
  7. 7.
    Bägli DJ, Joyner BD, Mahoney SR, McCulloch L. The hyaluronic acid receptor RHAMM is induced by stretch injury of rat bladder in vivo and influences smooth muscle cell contraction in vitro. J Urol. 1999;162:832–40.CrossRefPubMedGoogle Scholar
  8. 8.
    Glemain P, Riviére C, Lenormand L, Karam G, Bouchot O, Buzelin JM. Prolonged hydrodistention of the bladder for symptomatic treatment of interstitial cystitis: efficacy at 6 months and 1 year. Eur Urol. 2002;41:79–84.CrossRefPubMedGoogle Scholar
  9. 9.
    Hoke TP, Goldstein H, Saks EK, Vakili B. Hydrodistention of the bladder for the treatment of bladder pain syndrome/interstitial cystitis (BPS/IC). Neurourol Urodyn. 2017;36(3):784–6. doi: 10.1002/nau.23024.CrossRefPubMedGoogle Scholar
  10. 10.
    Niimi A, Nomiya A, Yamada Y, et al. Hydrodistension with or without fulguration of hunner lesions for interstitial cystitis: long-term outcomes and prognostic predictors. Neurourol Urodyn. 2016;35:965–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Ahmad I, Sarath Krishna NB, Meddings RN. Sequential hydrodistension and intravesical instillation of hyaluronic acid under general anaesthesia for treatment of refractory interstitial cystitis: a pilot study. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:543–6.CrossRefPubMedGoogle Scholar
  12. 12.
    Shao Y, Shen ZJ, Rui WB, Zhou WL. Intravesical instillation of hyaluronic acid prolonged the effect of bladder hydrodistention in patients with severe interstitial cystitis. Urology. 2010;75:547–50.CrossRefPubMedGoogle Scholar
  13. 13.
    Yang JY, Wei W, Lan YL, Liu JQ, Wang HB, Li S. Role of bladder hydrodistention and intravesical sodium hyaluronate in the treatment of interstitial cystitis. Urol J. 2015;12:2417–21.PubMedGoogle Scholar
  14. 14.
    Gürpinar T, Wong HX, Griffith DP. Electromotive administration of intravesical lidocaine in patients with interstitial cystitis. J Endourol. 1996;10:443–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Rosamilia A, Dwyer PL, Gibson J. Electromotive drug administration of lidocaine and dexamethasone followed by cystodistension in women with interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct. 1997;8:142–5.CrossRefPubMedGoogle Scholar
  16. 16.
    Riedl CR, Knoll M, Plas E, Pflüger H. Electromotive drug administration and hydrodistention for the treatment of interstitial cystitis. J Endourol. 1998;12:269–72.CrossRefPubMedGoogle Scholar
  17. 17.
    Platte RO, Parekh M, Minassian VA, Poplawsky D. Spontaneous bladder rupture following cystoscopy with hydrodistention and biopsy in a female patient with interstitial cystitis. Female Pelvic Med Reconstr Surg. 2011;17:149–52.CrossRefPubMedGoogle Scholar
  18. 18.
    Grossklaus DJ, Franke JJ. Vesical necrosis after hydrodistension of the urinary bladder in a patient with interstitial cystitis. BJU Int. 2000;86:140–1.CrossRefPubMedGoogle Scholar
  19. 19.
    Zabihi N, Allee T, Maher MG, Mourtzinos A, Raz S, Payne CK, Rodriguez LV. Bladder necrosis following hydrodistention in patients with interstitial cystitis. J Urol. 2007;177:149–52.CrossRefPubMedGoogle Scholar
  20. 20.
    Stav K, Lang E, Fanus Z, Leibovici D. Autonomic response during bladder hydrodistention in patients with bladder pain syndrome. J Urol. 2012;188:117–21.CrossRefPubMedGoogle Scholar
  21. 21.
    Kim SW, Son HS, Troya IS, Kim JY, Kim MJ, Fraser MO, Kim JH. Autonomic response during bladder hydrodistention reflects the severity of symptoms in patients with bladder pain syndrome/interstitial cystitis. Neurourol Urodyn. 2016;36(3):677–82. doi: 10.1002/nau.22994.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Department of UrologyLandesklinikum Baden-MoedlingBadenAustria

Personalised recommendations